Ryan Specialty Holdings (RYAN) Reaffirmed Growth Targets, Is The Stock Still Cheap?
Ryan Specialty Holdings (RYAN) has just paired solid Q3 2026 results with fresh signs of confidence. The insurer reported higher revenue and earnings, reaffirmed organic growth targets, and updated investors on capital returns.
Recent trading tells a mixed story for Ryan Specialty Holdings. The share price has climbed 16.4% over the past month to around $43.84, yet the stock is still down 13.4% on a year to date share price basis and the 1 year total shareholder return has declined 19%. However, the 5 year total shareholder return is positive at 21.1%, which suggests recent momentum is improving from a weaker stretch.
Scan how Ryan Specialty Holdings stacks up against other insurers facing similar pricing pressure and AI shifts by reviewing our hand-picked list of solid balance sheet and fundamentals (24 results).
Ryan Specialty Holdings recently rose on solid Q3 results and the announcement of a large buyback, yet longer-term returns remain under pressure. Does it make more sense to increase exposure now, or wait for a clearer valuation entry point?
Most Popular Narrative: 11% Undervalued
Ryan Specialty Holdings closed at $43.84, while the most followed narrative pegs fair value closer to $49.09. The current price therefore implies investors are still applying a clear discount despite recent earnings strength and buyback activity.
The current valuation and active buyback program, including US$302 million of repurchases in 2026 with authorization expanded to US$600 million, suggest that the share price does not fully reflect this narrative’s view that Ryan Specialty Holdings may be undervalued and that its earnings power may be underappreciated.
See why 5 investors see Ryan Specialty Holdings as 11% undervalued.
Result: Fair Value of $49.09 (UNDERVALUED)
Still, the Ryan Specialty Holdings narrative could be tested if builder’s risk remains weak or if rising competition in delegated authority binding puts pressure on fee income.
Find out about the key risks to this Ryan Specialty Holdings narrative.
Another View On Ryan Specialty Holdings Valuation
The fair value narrative points to Ryan Specialty Holdings as 11% undervalued, yet the market multiple tells a different story. The stock trades on a P/E of 44.7x, while the fair ratio sits at 25.8x and the US Insurance group sits near 11.5x. That gap points to meaningful valuation risk if sentiment cools, so which signal do you trust more?
See what the numbers say about this price in our detailed ratio workup, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed signals on Ryan Specialty Holdings valuation can easily pull you in opposite directions, so move quickly to test the numbers, weigh the sentiment, and decide where you stand on its 2 key rewards and 2 important warning signs.
Looking for more Ryan Specialty Holdings sized opportunities?
If Ryan Specialty Holdings has you thinking harder about price and quality, do not stop here. Broader idea hunting now could shape your portfolio for years.
- Target stronger risk and reward balance by screening resilient candidates through the 29 resilient stocks with low risk scores.
- Hunt for mispriced quality where fundamentals and valuation both work in your favor using the 33 high quality undervalued stocks.
- Spot lesser known prospects with robust financial footing before the crowd pays attention by checking the 19 high quality undiscovered gems.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com